NCT00140218 R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00125203 Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2/PHASE3
NCT00116558 Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation Status COMPLETED Phase NA
NCT00107770 Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) Status COMPLETED Phase PHASE1/PHASE2
NCT00072709 Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT00070993 Creatine for the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT00036413 A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT00035815 Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial Status COMPLETED Phase PHASE3
NCT00023075 Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis Status COMPLETED Phase N/A
NCT00021697 Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS Status COMPLETED Phase PHASE3
NCT00005766 Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT00005674 Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] Status COMPLETED Phase PHASE2
NCT00004771 Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease Status COMPLETED Phase PHASE2
NCT00004457 Determinants of Disease Severity in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase N/A